VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Stratpharma AG
Study ID
NCT05953090
Status
Recruiting

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • 7-0940 — DEVICE
    A non-hormonal and non-steroidal gel that supports vulvovaginal mucosal conditions and speeds up recovery post vaginal rejuvenation. It is a suitable alternative to vaginally administered estrogen and topical corticosteroids, that promotes a moist healing environment leading to faster re-epithelialization. The gel relieves symptoms such as itchiness, tenderness, dryness, burning sensation, painful intercourse (dyspareunia), painful urination (dysuria), rectal and defecating pain. It improves erythema, mucosal tissue thinning, erosions, fissures, ulcerations, scarring/adhesions and swelling. It is indicated for long-term use to maintain the health of the vaginal mucosa without the side effects of vaginally administered hormonal therapy and topical corticosteroids.

Study Details

Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will be treated with a novel gel dressing to test the short- and long-term safety and efficacy of the device.

Key Dates

Start date
Oct 30, 2023
Status verified
Feb 2026
Primary completion
Jun 30, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
2,000 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Feasibility

Primary Outcome Measure

Change in Vulvovaginal Symptoms Questionnaire (VSQ) score from baseline at 12 months. [ Time Frame: 12 months ]

Locations (14)

FacilityCityStateZIPSite coordinators
Cahaba Dermatology & Skin Health CenterBirminghamAlabama35244
Jennifer Perry
205 778-1564
Velvet Clinical ResearchBurbankCalifornia91506
Monica Torres
323-527-0907
Orange Coast Women's Medical GroupLaguna HillsCalifornia92653-
WR-PRI, LLC (Los Alamitos)Los AlamitosCalifornia90720
Linette Chhin
(714) 827-3668
Yasmin Herring, MD (PRINCIPAL_INVESTIGATOR)
WR-PRI, LLC (Newport Beach)Newport BeachCalifornia92660
Diana Nguyen
(949) 752-7910
Susan Park, MD (PRINCIPAL_INVESTIGATOR)
WR-Women's Health Care Research, LLCSan DiegoCalifornia92111
Cynthia Ho
(858) 505-8672
Robert Semo, MD (PRINCIPAL_INVESTIGATOR)
WR-Multi-Specialty Research AssociatesLake CityFlorida32055
Wanda North
(386)-438-8977
Cynthia Magrini, MD (PRINCIPAL_INVESTIGATOR)
WR-Mount Vernon Clinical Research, LLCSandy SpringsGeorgia30328
Kim Williams
(404) 843-4410
Gretchen Mitchell, MD (PRINCIPAL_INVESTIGATOR)
WR-Clinical Research Center of Nevada, LLCLas VegasNevada89106
Melissa Ellis
(702) 893-8968
Liliana Ruiz-Leon, DO (PRINCIPAL_INVESTIGATOR)
WR-Carolina Institute for Clinical ResearchFayettevilleNorth Carolina28303
Caitlyn Miller
(910) 302-8151
Connette McMahon, MD (PRINCIPAL_INVESTIGATOR)
WR-Charleston Clinical Trials, LLCCharlestonSouth Carolina29414
Vanessa Armetta
(843)-405-9834
Donald Hurley, DO (PRINCIPAL_INVESTIGATOR)
Southern UrogynecologyWest ColumbiaSouth Carolina29169
Tina McGready
803-457-7000
Andrea Pezzella, MD (PRINCIPAL_INVESTIGATOR)
WR-Medical Research Center of Memphis, LLCMemphisTennessee38210
Laurie Miles
(901) 507-1049
Todd Chappell, MD (PRINCIPAL_INVESTIGATOR)
WR-Global Medical Research, LLCDallasTexas75224
Vicki Martinez
(469) 297-3074
Roxanne Pero, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Birmingham, AL

By condition

Related Studies